Cardiovascular Players Could Be Eyeing Esperion
April 10, 2017 at 11:53 AM EDT
Takeover chatter prompted a 5.5 percent spike in Esperion Therapeutics Inc (NASDAQ: ESPR) Monday. A source familiar with the matter ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.